Sveriges mest populära poddar
Talking Points
Vetenskap

The EPIC-CAD Trial

12 min•2 juli 2025
Gi-Byoung Nam, Duk-Woo Park, and C. Michael Gibson weigh edoxaban monotherapy vs dual antithrombotic therapy for patients with AF and stable coronary artery disease.

Fler avsnitt av Talking Points

Visa alla avsnitt av Talking Points
The BETAMI-DANBLOCK Trial
•9 min
New York Valves 2026: Implications of the Proposed National Coverage Determination for TAVI
•1 tim 33 min
The PROCTOR Trial
•9 min
The SELUTION DeNovo Trial
•5 min
The VESALIUS-CV Trial
•7 min
The META-AF Trial
•5 min
Evolution of Pharmacotherapy in STEMI
•8 min
The CorCMR Trial
•6 min
The TUXEDO-2 Trial
•4 min
The FLOW Trial
•6 min

Talking Points med TCTMD finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.